Abbott Reviews Strong Ongoing Third Quarter Results Abbotts worldwide product sales increased 13.

Emerging markets sales were $2.6 billion, 21 up.0 % from the prior year and representing 26.1 % of total sales, with strong growth across all of Abbott’s operating divisions. The gross margin ratio was 60.4 % in the 3rd quarter, above Abbott’s earlier guidance, driven by favorable item mix. Abbott is certainly confirming its guidance for double-digit ongoing earnings-per-share growth for 2014 and is certainly narrowing its previous assistance range.

Actavis plc announced that it has launched a generic version of Intuniv®, as part of funds agreement withShire plc.Begun shipping the merchandise and Actavishas, under applicable Hatch Waxman guidelines, is entitled to 180 days of marketing exclusivity. Logo – Intuniv®is normally a prescription medicine used to treat Interest Deficit Hyperactivity Disorder in sufferers ages 6 to 17. For the 12-month period endingJune 30, 2014, Intuniv®acquired U.S. Sales of approximately$668 million, relating toIMS Healthdata. AboutActavis Actavis plc, headquartered inDublin, Ireland, can be a unique specialty pharmaceutical company centered on developing, manufacturing and commercializing top quality affordable generic and innovative branded pharmaceutical items for individuals around the global globe.Actavis plc announced that it has launched a generic version of Intuniv®, as part of funds agreement withShire plc.Begun shipping the merchandise and Actavishas, under applicable Hatch Waxman guidelines, is entitled to 180 days of marketing exclusivity. Logo – Intuniv®is normally a prescription medicine used to treat Interest Deficit Hyperactivity Disorder in sufferers ages 6 to 17. For the 12-month period endingJune 30, 2014, Intuniv®acquired U.S. Sales of approximately$668 million, relating toIMS Healthdata. AboutActavis Actavis plc, headquartered inDublin, Ireland, can be a unique specialty pharmaceutical company centered on developing, manufacturing and commercializing top quality affordable generic and innovative branded pharmaceutical items for individuals around the global globe.